What is Cytek Biosciences, Inc.'s income from continuing ops?

Cytek Biosciences, Inc. (CTKB) reported income from continuing ops of -$0.15 in Q1 2026.

How has Cytek Biosciences, Inc.'s income from continuing ops changed year-over-year?

Cytek Biosciences, Inc.'s income from continuing ops decreased by 66.7% year-over-year, from -$0.09 to -$0.15.

What does income from continuing ops mean?

Net income from business operations that are expected to continue, excluding gains or losses from discontinued segments. The best measure of ongoing earning power.

Cytek Biosciences, Inc. CTKB Income from Continuing Ops

Income from Continuing Ops at other companies

RevvityRVTY

$0.37+5.7%

FortiveFTV

$0.44+33.3%

Other financials

Income statement

See full

Revenue$44.1M+6.5%

Gross profit$21.3M+5.4%

Operating income-$18.5M-23.3%

Net income-$18.9M-65.5%

EPS (diluted)-$0.15-66.7%

Balance sheet

See full

Cash & equivalents$31.8M-66.6%

Total debt$16.8M+40.9%

Total equity$327.6M-13.7%

Total assets$449.1M-6.9%

Cash flow

See full

Operating cash flow-$2.7M-2,089%

CapEx$2.2M+155%

Free cash flow-$4.9M-403%

Valuation

See full

Market cap$577.27M+54.5%

Enterprise value$562.23M+93.7%

P/S2.8×+0.9×

Profitability

See full

Gross margin51.7%-3.2pp

Operating margin-21.5%—

Net margin-36.2%—

FCF margin-6.2%-15.1pp

Returns & leverage

See full

Return on equity-20.9%—

Debt / equity0.1×0.0×

Current ratio4.7×-0.9×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsPerBasicShare.

The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytek Biosciences, Inc.'s income from continuing ops.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytek Biosciences, Inc.'s income from continuing ops?: Cytek Biosciences, Inc. (CTKB) reported income from continuing ops of -$0.15 in Q1 2026.
How has Cytek Biosciences, Inc.'s income from continuing ops changed year-over-year?: Cytek Biosciences, Inc.'s income from continuing ops decreased by 66.7% year-over-year, from -$0.09 to -$0.15.
What does income from continuing ops mean?: Net income from business operations that are expected to continue, excluding gains or losses from discontinued segments. The best measure of ongoing earning power.